Author:
Favre G, ,Beksaç M,Bacigalupo A,Ruutu T,Nagler A,Gluckman E,Russell N,Apperley J,Szer J,Bradstock K,Buzyn A,Matcham J,Gratwohl A,Schmitz N
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference33 articles.
1. Gratwohl A, Baldomero H, Horisberger B et al. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374–2386.
2. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277–284.
3. Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation vs autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353–357.
4. Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175–181.
5. Powles R, Mehta J, Kulkarni S et al. Allogeneic blood and bone-marrow stem cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000; 355: 1231–1237.